CINECA IRIS Institutional Research Information System

REIMONDO, Giuseppe Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.119
EU - Europa 4.678
AS - Asia 2.411
SA - Sud America 346
AF - Africa 101
OC - Oceania 86
Continente sconosciuto - Info sul continente non disponibili 8
Totale 13.749
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.899
IT - Italia 1.087
CN - Cina 1.080
DE - Germania 554
SE - Svezia 470
IE - Irlanda 447
UA - Ucraina 341
FR - Francia 319
GB - Regno Unito 240
JP - Giappone 238
FI - Finlandia 233
KR - Corea 210
PL - Polonia 195
SG - Singapore 184
TR - Turchia 161
BR - Brasile 147
VN - Vietnam 147
ES - Italia 141
CA - Canada 133
AT - Austria 123
IN - India 93
AU - Australia 82
RU - Federazione Russa 73
AR - Argentina 70
MX - Messico 68
BE - Belgio 66
NL - Olanda 57
GR - Grecia 53
CO - Colombia 52
HK - Hong Kong 51
HU - Ungheria 44
CL - Cile 36
RO - Romania 36
CH - Svizzera 35
IR - Iran 33
PT - Portogallo 33
TW - Taiwan 31
DK - Danimarca 29
RS - Serbia 29
DZ - Algeria 27
CZ - Repubblica Ceca 24
TH - Thailandia 24
SN - Senegal 23
IL - Israele 22
IQ - Iraq 19
MY - Malesia 18
ZA - Sudafrica 18
ID - Indonesia 17
PH - Filippine 17
PE - Perù 16
PK - Pakistan 13
TN - Tunisia 12
EC - Ecuador 11
SA - Arabia Saudita 11
SI - Slovenia 10
VE - Venezuela 9
EG - Egitto 8
EU - Europa 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
BA - Bosnia-Erzegovina 6
HR - Croazia 6
NO - Norvegia 6
SY - Repubblica araba siriana 5
UY - Uruguay 5
BH - Bahrain 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
NZ - Nuova Zelanda 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
AM - Armenia 3
BG - Bulgaria 3
CR - Costa Rica 3
MA - Marocco 3
MU - Mauritius 3
NI - Nicaragua 3
TZ - Tanzania 3
BY - Bielorussia 2
CY - Cipro 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
LT - Lituania 2
LU - Lussemburgo 2
LV - Lettonia 2
PA - Panama 2
QA - Qatar 2
SM - San Marino 2
AP - ???statistics.table.value.countryCode.AP??? 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
HN - Honduras 1
IM - Isola di Man 1
MC - Monaco 1
MM - Myanmar 1
MT - Malta 1
Totale 13.747
Salva come PNG Salva come JPEG
Città #
Chandler 800
Beijing 669
Dublin 437
Fairfield 378
Houston 342
Ashburn 284
Ann Arbor 229
Redwood City 203
Jacksonville 200
Wilmington 187
Torino 180
Woodbridge 179
Nyköping 162
Seattle 158
Medford 141
Cambridge 139
Princeton 126
Singapore 125
Villeurbanne 115
Warsaw 114
Dearborn 113
Vienna 108
Dong Ket 96
Pisa 87
Milan 84
Turin 72
Rochester 59
Guangzhou 54
Rome 50
Shanghai 49
Tokyo 49
Boston 46
New York 45
Toronto 43
Istanbul 42
Los Angeles 40
Fremont 38
Munich 38
Ankara 33
Buenos Aires 33
Boardman 31
Bogotá 30
Würzburg 30
San Diego 29
Helsinki 28
Paris 28
Seoul 28
Chicago 27
Hangzhou 27
Moscow 27
Brussels 25
Budapest 24
Hefei 23
Taipei 23
Santiago 22
Okazaki 21
Düsseldorf 20
London 20
Norwalk 19
Lachine 18
Seongnam 18
Athens 17
Nanjing 17
Phoenix 17
Madrid 16
Tehran 16
Lima 15
Osaka 15
Padova 15
São Paulo 15
Washington 15
Zurich 15
Brno 14
Hong Kong 14
Lappeenranta 14
Mountain View 14
Portland 14
Sydney 14
Belgrade 13
Curitiba 13
Falls Church 13
Florence 13
Silver Spring 13
Trieste 13
Uberlândia 13
Berlin 12
Brisbane 12
Chengdu 12
San Jose 12
Fukuoka 11
Lund 11
Ottawa 11
Changsha 10
Frankfurt am Main 10
Gliwice 10
Jinan 10
Leiden 10
Naples 10
Nürnberg 10
Piemonte 10
Totale 7.374
Salva come PNG Salva come JPEG
Nome #
New perspectives for mitotane treatment of adrenocortical carcinoma 1.039
Autonomous hypercortisolism: definition and clinical implications 587
Long-term follow-up in adrenal incidentalomas: an Italian Multicenter Study. 467
AME position statement on adrenal incidentaloma. 408
Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas 358
ENSAT registry-based randomized clinical trials for adrenocortical carcinoma 355
Thyroid and colorectal cancer screening in acromegaly patients: Should it be different from that in the general population? 312
Screening of Cushing's Syndrome in Outpatients with Type 2 Diabetes: Results of a Prospective Multicentric Study in Italy. 284
Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas 270
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. 262
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: A multicenter study 261
Surgical remission of Cushing's syndrome reduces cardiovascular risk. 244
Adjuvant mitotane treatment for adrenocortical carcinoma 240
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma 238
Analysis of BCLI, N363S and ER22/23EK polymorphisms of the glucocorticoid receptor gene in adrenal incidentalomas 230
Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease 218
Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency. 213
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma 187
Predictors of morbidity and mortality in acromegaly: an Italian survey. 174
Growth hormone values after an oral glucose load do not add clinically useful information in patients with acromegaly on long-term somatostatin receptor ligand treatment. 167
Novel mutation of PPOX gene in a patient with abdominal pain and syndrome of inappropriate antidiuresis. 162
Acromegaly is associated with increased cancer risk: a survey in Italy 159
Comparison of Reverse Triage with National Early Warning Score, Sequential Organ Failure Assessment and Charlson Comorbidity Index to classify medical inpatients of an Italian II level hospital according to their resource's need. 155
Determination of salivary cortisol to assess time related changes of the adrenal response to stress in critically ill patients 152
Analysis of BclI, N363S and ER22/23EK polymorphism of the glucocorticoid receptor gene in a large series of patients with adrenal incidentaloma 144
Laboratory differentiation of Cushing's syndrome 141
Inpatient disposition in overcrowded hospitals: is it safe and effective to use reverse triage and readmission screening tools for appropriate discharge? An observational prospective study of an Italian II level hospital 138
Adrenal incidentaloma, a five year experience. 134
May an adrenal incidentaloma change its nature? 134
[Subclinical Cushing's syndrome in adrenal incidentalomas] 132
Long term safety of recombinant human growth hormone (rhGH) in patients treated during childhood 132
Insights on the natural history of adrenal incidentalomas 124
Evaluation of midnight salivary cortisol as a predictor factor for common carotid arteries intima media thickness in patients with clinically inapparent adrenal adenomas 118
Adrenal incidentalomas and subclinical Cushing's syndrome: is there evidence for glucocorticoid-induced osteoporosis? 116
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 109
Adrenal incidentalomas are tied to increased risk of diabetes: findings from a prospective study 109
Adrenocortical Carcinoma with Hypercortisolism. 107
Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome. 105
What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study 104
Adjuvant mitotane treatment: a prospective experience at the San luigi Hospital, University of Turin, Italy, USA, 2008 103
Evaluation of cardiovascular risk factors in patients with incidentally discovered adrenal adenoma during a follow-up longer than five years 103
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study 103
Acute Primary Adrenal Insufficiency after Hip Replacement in a Patient with Acute Intermittent Porphyria. 100
Cyclic Cushing's syndrome due to ectopic ACTH secretion by an adrenal pheochromocytoma. 99
Valutazione prospettica di pazienti operati radicalmente per carcinoma corticosurrenalico in trattamento con mitotane adiuvante: correlazioni tra indici di massa corporea, livelli di mitotanemia ed efficacia. 98
Subclinical Cushing's syndrome 96
A prospective study on adjuvant mitotane 96
Sindrome di Cushing: l’esperienza dell’Ospedale San Luigi di Orbassano 93
Misdiagnosis of Cushing's syndrome in a patient receiving rifampicin therapy for tuberculosis. 89
Epidemiology of acromegaly in Italy 88
The San Luigi hospital experience with adjuvant mitotane treatment in patients with adrenocortical cancer following radical resection 87
Sindrome di cushing: esperienza dell'ospedale San Luigi di Orbassano in una serie consecutiva di 117 pazienti 87
Adrenal pseudocyst mimicking cancer: a case report 86
Adrenal incidentaloma: a new cause of the metabolic syndrome? 85
Desmopressin test in mild Cushing syndrome. 84
Early introduction of simulation in the medical curriculum: the MedInTo perspective 83
Evaluation of Cardiovascular Risk Factors in Patients with Incidentally Discovered Adrenal Adenoma during a Follow-Up Longer Than Five Years. 81
Cardiovascular risk factors in patients with Cushing’s syndrome: data from a long term follow up after treatment 80
Autocrine down-regulation of glucocorticoid receptors by interleukin-11 in human osteoblast-like cell lines. 78
Circadian profile of serum melatonin in patients with Cushing's syndrome or acromegaly. 77
Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Renin-Angiotensin-Aldosterone System 77
Is Follow-up of Adrenal Incidentalomas Always Mandatory? 75
A multicenter epidemiological study on second malignancy in non-syndromic pheochromocytoma/paraganglioma patients in Italy 75
Unwanted hormonal and metabolic effects of postoperative adjuvant mitotane treatment for adrenocortical cancer 74
L'esperienza dell'ospedale san Luigi nel trattamento con mitotane adiuvante in pazienti operati radicalmente per carcinoma corticosurrenalico. 72
Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome 71
PREOPERATIVE TREATMENT WITH METYRAPONE IN PATIENTS WITH CUSHING'S SYNDROME DUE TO ADRENAL ADENOMA. 69
The combined low-dose dexamethasone suppression corticotropin-releasing hormone test as a tool to rule out Cushing's syndrome 69
Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome. 68
Comparison of 1-mg versus 8-mg dexamethasone suppression test (DST) in patients with clinically inapparent adrenal adenoma 67
Emerging drugs for adrenocortical carcinoma 67
Demographic Data, Co-Morbidities, Malignancies and Mortality from the First Large-Scale Italian Study on Acromegaly. 66
Hyperhomocysteinemia in patients with Cushing's syndrome 66
Management of adrenal incidentalomas 62
Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing's syndrome 62
Secondary hypoadrenalism 62
Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly 62
Midnight salivary cortisol for diagnosis of subclinical Cushing’s syndrome in patients with clinically inapparent adrenocortical adenoma. 62
Sindrome di Cushing: l'esperienza dell'ospedale San Luigi in una serie consecutiva di 117 pazienti 59
The value of dehydroepiandrosterone sulfate measurement in the differentiation between benign and malignant adrenal masses. 56
Colonoscopic screening and follow-up in patients with acromegaly: a multicenter study in Italy 56
Predictors of recurrence of pheochromocytoma and paraganglioma: a multicenter study in Piedmont, Italy 56
Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors : A Cross-Sectional Multicenter Study 56
Long-term follow-up in adrenal incidentalomas: an Italian Multicentre Study 55
Rapporto tra acromegalia e neoplasia: fantasia o realtà? 54
Screening of Cushing's syndrome in adult patients with newly diagnosed diabetes mellitus 54
SEX DIFFERENCES ON MITOTANE CONCENTRATION AND TREATMENT OUTCOME IN PATIENTS WITH ADRENOCORTICAL CARCINOMA 53
Ectopic ACTH syndrome: molecular bases and clinical heterogeneity. 52
Sex Differences on Mitotane Concentration and Treatment Outcome in Patients with Adrenocortical Carcinoma 51
Molecular mechanisms of mitotane action in adrenocortical cancer based on in vitro studies 51
Prolonged adrenal insufficiency after the discontinuation of mitotane therapy 49
The limited value of the desmopressin test in the diagnostic approach to Cushing's syndrome 48
May an altered hypothalamo-pituitary-adrenal axis contribute to cortical bone damage in primary hyperparathyroidism? 48
Risk of cardiovascular events in adrenal incidentalomas: an Italian long-term follow-up study 48
Changes in bone mineral density, lean body mass and fat content as measured by dual energy x-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy. 47
The patients with incidentally discovered adrenal adenoma (incidentaloma) are not at increased risk of osteoporosis. 46
Reversibility of Acute Adrenal Insufficiency after hip Replacement: A Case Series 46
Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma 43
Prevalence of adrenal incidentaloma in a contemporary computerized tomography series 43
Sindrome di Cushing: l’esperienza dell’Ospedale San Luigi in una serie consecutiva di 117 pazienti 43
Totale 13.225
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.792
article - articoli 0
book - libri 0
conference - conferenze 5.409
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.201
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.925 105 96 106 195 124 247 230 205 237 150 125 105
2020/20211.822 137 91 154 94 139 89 173 148 149 199 144 305
2021/20222.274 133 111 131 209 188 115 174 143 120 175 389 386
2022/20232.828 269 236 108 237 243 565 187 204 334 120 187 138
2023/20242.069 220 249 125 162 179 198 195 180 50 137 193 181
2024/202592 92 0 0 0 0 0 0 0 0 0 0 0
Totale 14.221